• 1
    Tay CY, Windsor HM, Thirriot F, et al. Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. Aliment Pharmacol Ther 2012; 36: 107683.
  • 2
    Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection–the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 64664.
  • 3
    De Francesco V, Giorgio F, Hassan C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010; 19: 40914.
  • 4
    Yoon JH, Baik GH, Sohn KM, et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol 2012; 18: 662834.
  • 5
    Cammarota G, Tursi A, Papa A, Fedeli G, Gasbarrini G. Sensitivity testing for Helicobacter pylori should be more widely available. BMJ 1996; 313: 107980.
  • 6
    Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut 1997; 41(Suppl. 2): S10-8
  • 7
    Tursi A, Picchio M, Elisei W. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. J Gastrointestin Liver Dis 2012; 21: 1338.